Ascentage Pharma Group International (AAPG) Non-Current Assets: 2023-2025

  • Ascentage Pharma Group International's Non-Current Assets was N/A to $157.3 million in Q2 2025 from the same period last year, while for Jun 2025 it was $157.3 million, marking a year-over-year change of. This contributed to the annual value of $156.7 million for FY2024, which is 4.23% down from last year.
  • Ascentage Pharma Group International's Non-Current Assets amounted to $157.3 million in Q2 2025, which was up 0.37% from $156.7 million recorded in Q4 2024.
  • Over the past 5 years, Ascentage Pharma Group International's Non-Current Assets peaked at $160.6 million during Q4 2023, and registered a low of $156.7 million during Q4 2024.
  • Over the past 3 years, Ascentage Pharma Group International's median Non-Current Assets value was $157.3 million (recorded in 2025), while the average stood at $158.2 million.
  • Data for Ascentage Pharma Group International's Non-Current Assets shows a maximum YoY dropped of 2.43% (in 2024) over the last 5 years.
  • Over the past 3 years, Ascentage Pharma Group International's Non-Current Assets (Quarterly) stood at $160.6 million in 2023, then decreased by 2.43% to $156.7 million in 2024, then reached $157.3 million in 2025.
  • Its last three reported values are $157.3 million in Q2 2025, $156.7 million for Q4 2024, and $160.6 million during Q4 2023.